title: Metabolic approaches to antihypertensive treatment in diabetic patients.
authors.affiliation: Department of Medical and Surgical Sciences, Sant'Orsola Malpighi, University of Bologna, Bologna, Italy.
authors.forename: Arrigo F
authors.initials: AF
authors.lastname: Cicero
authors.affiliation: Division of Cardiology, Department of Clinical and Molecular Medicine, Faculty of Medicine and Psychology, University of Rome 'Sapienza', Sant'Andrea Hospital, Rome and IRCCS Neuromed, Pozzilli (IS), Italy.
authors.forename: Giuliano
authors.initials: G
authors.lastname: Tocci
mesh_terms: D047228:Angiotensin II Type 1 Receptor Blockers / Q000627:therapeutic use*; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001562:Benzimidazoles / Q000627:therapeutic use*; D001565:Benzoates / Q000627:therapeutic use*; D002121:Calcium Channel Blockers / Q000627:therapeutic use*; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D004232:Diuretics / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D006852:Hydrochlorothiazide / Q000627:therapeutic use*; D006973:Hypertension / Q000188:drug therapy*; D007333:Insulin Resistance; D019808:Losartan / Q000627:therapeutic use*; D008297:Male; D009543:Nifedipine / Q000031:analogs & derivatives*
chemical_list: D047228:Angiotensin II Type 1 Receptor Blockers; D000959:Antihypertensive Agents; D001562:Benzimidazoles; D001565:Benzoates; D002121:Calcium Channel Blockers; D004232:Diuretics; D006852:Hydrochlorothiazide; D009543:Nifedipine; D019808:Losartan